Provided by Tiger Trade Technology Pte. Ltd.

Immunome Inc.

24.97
-1.1500-4.40%
Post-market: 24.970.00000.00%16:56 EDT
Volume:729.85K
Turnover:18.44M
Market Cap:2.84B
PE:-10.05
High:26.08
Open:25.69
Low:24.91
Close:26.12
52wk High:30.06
52wk Low:8.93
Shares:113.58M
Float Shares:108.11M
Volume Ratio:0.96
T/O Rate:0.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4851
EPS(LYR):-2.4315
ROE:-64.03%
ROA:-37.78%
PB:5.40
PE(LYR):-10.27

Loading ...

Immunome Q1 net loss widens to $53.84 million

Reuters
·
May 13

Immunome Q1 Operating Expenses USD 59.331 Million

THOMSON REUTERS
·
May 13

Assessing Immunome (IMNM) Valuation As Premium P/B And DCF Signals Point In Different Directions

Simply Wall St.
·
May 08

Immunome grants 450,000 inducement stock options to 19 new employees at $22.73/share

Reuters
·
May 06

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
May 06

Craig-Hallum Keeps Their Buy Rating on Immunome (IMNM)

TIPRANKS
·
Apr 29

Immunome submits FDA NDA for varegacestat in adult desmoid tumors

Reuters
·
Apr 29

Immunome Announces Submission of New Drug Application to U.S. FDA for Varegacestat for the Treatment of Adults With Desmoid Tumors

THOMSON REUTERS
·
Apr 29

Immunome announces annual shareholder meeting webcast

Reuters
·
Apr 25

Immunome to present Phase 3 RINGSIDE desmoid tumor data in ASCO oral session

Reuters
·
Apr 21

Immunome Announces Oral Presentation of Phase 3 Ringside Data at 2026 Asco Annual Meeting

THOMSON REUTERS
·
Apr 21

Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (GEHC), Immunome (IMNM) and Eli Lilly & Co (LLY)

TIPRANKS
·
Apr 17

Immunome (IMNM) Receives a Buy from LifeSci Capital

TIPRANKS
·
Apr 07

Immunome CSO Jack Higgins disposes of $0.2 million common shares

Reuters
·
Apr 04

Immunome CFO Max Rosett disposes of common shares worth 1.4 million

Reuters
·
Apr 04

BRIEF-Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Apr 03

Immunome grants inducement stock options for 188,500 shares to 13 new hires

Reuters
·
Apr 03

Immunome CEO Clay Siegall buys $0.5 million in common shares

Reuters
·
Apr 01

Immunome Director Philip Wagenheim Disposes of Common Shares Worth USD 1,335,000

Reuters
·
Mar 24